Literature DB >> 19819958

The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides.

Andreas Stengel1, David Keire, Miriam Goebel, Lena Evilevitch, Brian Wiggins, Yvette Taché, Joseph R Reeve.   

Abstract

The correct identification of circulating molecular forms and measurement of peptide levels in blood entails that the endocrine peptide being studied is stable and recovered in good yields during blood processing. However, it is not clear whether this is achieved in studies using standard blood processing. Therefore, we compared peptide concentration and form of 12 (125)I-labeled peptides using the standard procedure (EDTA-blood on ice) and a new method employing Reduced temperatures, Acidification, Protease inhibition, Isotopic exogenous controls, and Dilution (RAPID). During standard processing there was at least 80% loss for calcitonin-gene-related peptide and cholecystokinin-58 (CCK-58) and more than 35% loss for amylin, insulin, peptide YY forms (PYY((1-36)) and PYY((3-36))), and somatostatin-28. In contrast, the RAPID method significantly improved the recovery for 11 of 12 peptides (P < 0.05) and eliminated the breakdown of endocrine peptides occurring after standard processing as reflected in radically changed molecular forms for CCK-58, gastrin-releasing peptide, somatostatin-28, and ghrelin. For endogenous ghrelin, this led to an acyl/total ghrelin ratio of 1:5 instead of 1:19 by the standard method. These results show that the RAPID method enables accurate assessment of circulating gut peptide concentrations and forms such as CCK-58, acylated ghrelin, and somatostatin-28. Therefore, the RAPID method represents an efficacious means to detect circulating variations in peptide concentrations and form relevant to the understanding of physiological function of endocrine peptides.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819958      PMCID: PMC2775981          DOI: 10.1210/en.2009-0697

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

1.  Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones.

Authors:  M J Evans; J H Livesey; M J Ellis; T G Yandle
Journal:  Clin Biochem       Date:  2001-03       Impact factor: 3.281

2.  Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples.

Authors:  Hiroshi Hosoda; Kentaro Doi; Noritoshi Nagaya; Hiroyuki Okumura; Eiichiro Nakagawa; Mitsunobu Enomoto; Fumiaki Ono; Kenji Kangawa
Journal:  Clin Chem       Date:  2004-06       Impact factor: 8.327

3.  High-performance liquid chromatographic (HPLC) and HPLC-mass spectrometric (MS) analysis of the degradation of the luteinizing hormone-releasing hormone (LH-RH) antagonist RS-26306 in aqueous solution.

Authors:  R G Strickley; M Brandl; K W Chan; K Straub; L Gu
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

4.  CCK-58 is the only detectable endocrine form of cholecystokinin in rat.

Authors:  Joseph R Reeve; Gary M Green; Peter Chew; Viktor E Eysselein; David A Keire
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-04-09       Impact factor: 4.052

Review 5.  General principles of radioimmunoassay.

Authors:  S A Berson; R S Yalow
Journal:  Clin Chim Acta       Date:  1968-09       Impact factor: 3.786

Review 6.  Ghrelin: structure and function.

Authors:  Masayasu Kojima; Kenji Kangawa
Journal:  Physiol Rev       Date:  2005-04       Impact factor: 37.312

7.  LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications.

Authors:  Lixin Wang; Nicole R Basa; Almaas Shaikh; Andrew Luckey; David Heber; David H St-Pierre; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-10       Impact factor: 4.052

8.  Plasma concentrations of cholecystokinin, CCK-8, and CCK-33, 39 in rats, determined by a method based on enzyme digestion of gastrin before HPLC and RIA detection of CCK.

Authors:  A Lindén; M Carlquist; S Hansen; K Uvnäs-Moberg
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

9.  Mammalian bombesin as a hormone in ovine pregnancy: ontogeny, origin, and molecular forms.

Authors:  A Giraud; L Parker; D Taupin; K Hardy; A Shulkes
Journal:  Am J Physiol       Date:  1993-12

10.  Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats.

Authors:  U R Fölsch; P Cantor; H M Wilms; A Schafmayer; H D Becker; W Creutzfeldt
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

View more
  46 in total

Review 1.  Secretin: Should we revisit its metabolic outcomes?

Authors:  D H St-Pierre; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

2.  A guide for measurement of circulating metabolic hormones in rodents: Pitfalls during the pre-analytical phase.

Authors:  Maximilian Bielohuby; Sarah Popp; Martin Bidlingmaier
Journal:  Mol Metab       Date:  2012-08-09       Impact factor: 7.422

3.  A primary colonic crypt model enriched in enteroendocrine cells facilitates a peptidomic survey of regulated hormone secretion.

Authors:  Svetlana E Nikoulina; Nancy L Andon; Kevin M McCowen; Michelle D Hendricks; Carolyn Lowe; Steven W Taylor
Journal:  Mol Cell Proteomics       Date:  2010-01-15       Impact factor: 5.911

4.  A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood.

Authors:  Pauline Teuffel; Miriam Goebel-Stengel; Tobias Hofmann; Philip Prinz; Sophie Scharner; Jan L Körner; Carsten Grötzinger; Matthias Rose; Burghard F Klapp; Andreas Stengel
Journal:  J Vis Exp       Date:  2016-04-28       Impact factor: 1.355

5.  Abdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2.

Authors:  Andreas Stengel; Miriam Goebel-Stengel; Lixin Wang; Almaas Shaikh; Nils W G Lambrecht; Jean Rivier; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

6.  Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats.

Authors:  L Wang; N P Murphy; A Stengel; M Goebel-Stengel; D H St Pierre; N T Maidment; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-03-23       Impact factor: 3.598

7.  Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats.

Authors:  A Stengel; M Goebel-Stengel; L Wang; A Luckey; E Hu; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2011-05-13       Impact factor: 3.598

Review 8.  Regulation of food intake: the gastric X/A-like endocrine cell in the spotlight.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Gastroenterol Rep       Date:  2009-12

9.  CCK-58 elicits both satiety and satiation in rats while CCK-8 elicits only satiation.

Authors:  Joost Overduin; James Gibbs; David E Cummings; Joseph R Reeve
Journal:  Peptides       Date:  2014-01-24       Impact factor: 3.750

Review 10.  Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2009-11-26       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.